Furthermore, chrysin has been observed to downregulate the protein expression of phosphorylated extracellular signal-regulated kinase 1 and 2 (p-ERK1/2), culminating in its anticancer activity in cancer cell lines through the modulation of the ERK/Nrf2 signaling pathway, as visually depicted in (Fig. 6). The gene discussed is MAPK3; the disease is cancer.